ENMD-2076

934353-76-1

PDGFR|||Src|||FLT|||VEGFR|||c-RET|||FGFR|||Apoptosis|||Aurora Kinase

Tyrosine Kinase/Adaptors|||Angiogenesis|||Apoptosis|||Cell Cycle/Checkpoint|||Chromatin/Epigenetic

0.98

ENMD-2076, a multi-targeted kinase inhibitor, has specific activity against Aurora A, Flt3, KDR/VEGFR2, Flt4/VEGFR3, FGFR1, FGFR2, Src, PDGFR?.

CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(\C=C\c2ccccc2)n1

C21H25N7

375.47

Cool pack

-20°C